The FDA has approved Insulet SmartAdjust automatic insulin dosing technology for type 2 diabetes in those aged 18 and older. The interoperable automated glycemic controller software connects to an alternate controller-enabled insulin pump (ACE pump) and integrated continuous glucose monitor (ICGM). Together, they automatically adjust insulin delivery to those with diabetes. Prior to clearance, the […]
Market News and Data brought to you by Benzinga APIsThe post FDA Clears First Device to Automatically Dose Insulin for Type 2 Diabetes appeared first on Techopedia.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in